Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Julia Zumpano, RD, LD, has been a registered dietician at the Cleveland Clinic Center for Human Nutrition for almost 20 years ...

A new study from Imperial has shown that the physical structure of food influences the hormones released as part of digestion. These hormones include glucagon-like peptide-1 (GLP-1), GIP and PYY ...

For people with Type 1 diabetes, developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels ...

Food Structure May Influence Whether You Feel “Full” Yet The physical structure of food can affect the hormones that are released during digestion, suggesting new ways to potentially "hack" our diet.

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...

Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...

MANY bitter-tasting substances produced by plants are known, but no conclusive relationship between bitterness and chemical structure has been proposed. Shallenberger and Acree 1 recently related ...

For weight loss or weight management A brain hormone called GLP-1 regulates appetite. Wegovy belongs to a group of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), originally developed for type 2 diabetes treatment, have demonstrated in randomised ...